Skip to main content
. 2013 Jan 11;76(3):475–483. doi: 10.1111/bcp.12078

Figure 1.

Figure 1

Median (± interquartile range) indinavir concentration vs. time curves for HIV-infected pregnant women using indinavir/ritonavir 400/100 mg twice daily during the second and third trimesters of pregnancy and post-partum. Dashed line represents the typical 50th percentile concentrations in non-pregnant historical Thai adults. Inline graphic, second trimester; Inline graphic, third trimester; Inline graphic, post-partum; Inline graphic, non-pregnant